Review



reference strain a fumigatus af293  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    ATCC reference strain a fumigatus af293
    Screening of the MedChemExpress (MCE) Antiviral Compound Library at a final concentration of 16 µM against A. fumigatus <t>AF293</t> in the presence of a subinhibitory concentration of AmB (0.25 µg/mL). Fungal growth was assessed after 48 hours by measuring the optical density at 530 nm. Green dots indicate compounds that achieved ≥80% growth inhibition compared to the no-drug control. The chemical structures of the selected hit compounds, cobicistat (COB) and elvitegravir (ELV), are shown above the screening plot.
    Reference Strain A Fumigatus Af293, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 97 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/reference+strain+a+fumigatus+af293/Aspergillus+fumigatus+Fresenius/pmc13016342-102-24-29
    Average 95 stars, based on 97 article reviews
    reference strain a fumigatus af293 - by Bioz Stars, 2026-10
    95/100 stars

    Images

    1) Product Images from "Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species"

    Article Title: Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species

    Journal: PLOS One

    doi: 10.1371/journal.pone.0344286

    Screening of the MedChemExpress (MCE) Antiviral Compound Library at a final concentration of 16 µM against A. fumigatus AF293 in the presence of a subinhibitory concentration of AmB (0.25 µg/mL). Fungal growth was assessed after 48 hours by measuring the optical density at 530 nm. Green dots indicate compounds that achieved ≥80% growth inhibition compared to the no-drug control. The chemical structures of the selected hit compounds, cobicistat (COB) and elvitegravir (ELV), are shown above the screening plot.
    Figure Legend Snippet: Screening of the MedChemExpress (MCE) Antiviral Compound Library at a final concentration of 16 µM against A. fumigatus AF293 in the presence of a subinhibitory concentration of AmB (0.25 µg/mL). Fungal growth was assessed after 48 hours by measuring the optical density at 530 nm. Green dots indicate compounds that achieved ≥80% growth inhibition compared to the no-drug control. The chemical structures of the selected hit compounds, cobicistat (COB) and elvitegravir (ELV), are shown above the screening plot.

    Techniques Used: Drug discovery, Concentration Assay, Inhibition, Control

    A. fumigatus AF293 conidia (5 × 10⁴ conidia/mL) were incubated in RPMI-MOPS medium and fungal growth was monitored over a 48-hour period by measuring optical density at 530 nm at regular time intervals. (A) Growth kinetics of untreated control versus monotherapies: AmB at 0.25, 0.5, and 2 µg/mL; COB and ELV at 4 µg/mL. Only AmB at 2 µg/mL resulted in substantial inhibition, while sub-inhibitory doses and antiretrovirals alone had minimal impact. (B) Comparison of COB combinations: AmB 0.25/COB 4, AmB 0.5/COB 2, and AmB 0.5/COB 4 µg/mL. All combinations showed enhanced inhibition versus monotherapies, with the 0.5/4 pairing sustaining growth suppression across 48 hours. (C) Comparison of ELV combinations: AmB 0.25/ELV 4, AmB 0.5/ELV 2, and AmB 0.5/ELV 4 µg/mL. As with COB, the highest dose pairing (0.5/4) achieved the most durable inhibition.
    Figure Legend Snippet: A. fumigatus AF293 conidia (5 × 10⁴ conidia/mL) were incubated in RPMI-MOPS medium and fungal growth was monitored over a 48-hour period by measuring optical density at 530 nm at regular time intervals. (A) Growth kinetics of untreated control versus monotherapies: AmB at 0.25, 0.5, and 2 µg/mL; COB and ELV at 4 µg/mL. Only AmB at 2 µg/mL resulted in substantial inhibition, while sub-inhibitory doses and antiretrovirals alone had minimal impact. (B) Comparison of COB combinations: AmB 0.25/COB 4, AmB 0.5/COB 2, and AmB 0.5/COB 4 µg/mL. All combinations showed enhanced inhibition versus monotherapies, with the 0.5/4 pairing sustaining growth suppression across 48 hours. (C) Comparison of ELV combinations: AmB 0.25/ELV 4, AmB 0.5/ELV 2, and AmB 0.5/ELV 4 µg/mL. As with COB, the highest dose pairing (0.5/4) achieved the most durable inhibition.

    Techniques Used: Incubation, Control, Inhibition, Comparison

    (A) Brightfield microscopy images of A. fumigatus AF293 grown for 16 h in RPMI-1640 medium under the following conditions: untreated control, amphotericin B (AmB, 0.03 µg/mL), cobicistat (COB, 16 µg/mL), elvitegravir (ELV, 16 µg/mL), AmB/COB, and AmB/ELV. Images were acquired at 20 × magnification on a Nikon Eclipse Ti2 microscope, with a 100 µm scale bar shown. (B) Quantification of hyphal lengths under each condition was done using ImageJ software. For each variable, 15 hyphae were measured, and data are presented as mean. Statistical significance was assessed using one-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. Asterisks indicate significant differences relative to the untreated control, *** (P < 0.005) and **** (P < 0.0001).
    Figure Legend Snippet: (A) Brightfield microscopy images of A. fumigatus AF293 grown for 16 h in RPMI-1640 medium under the following conditions: untreated control, amphotericin B (AmB, 0.03 µg/mL), cobicistat (COB, 16 µg/mL), elvitegravir (ELV, 16 µg/mL), AmB/COB, and AmB/ELV. Images were acquired at 20 × magnification on a Nikon Eclipse Ti2 microscope, with a 100 µm scale bar shown. (B) Quantification of hyphal lengths under each condition was done using ImageJ software. For each variable, 15 hyphae were measured, and data are presented as mean. Statistical significance was assessed using one-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. Asterisks indicate significant differences relative to the untreated control, *** (P < 0.005) and **** (P < 0.0001).

    Techniques Used: Microscopy, Control, Software

    Biofilms were established by incubating A. fumigatus AF293 (1 × 10⁴ CFU/mL) in RPMI-1640 medium for 24 hours in the presence of cobicistat or elvitegravir (16 µg/mL), either alone or combined with a sub-inhibitory concentration of amphotericin B (0.015 µg/mL; 0.0075 × MIC). Biofilm biomass was quantified using crystal violet staining, followed by solubilization and absorbance measurement at 600 nm. Statistical analysis was performed using one-way ANOVA with Dunnett’s post hoc test. Significant reductions were observed for both AmB/COB and AmB/ELV combinations. Asterisks indicate significant differences relative to the untreated control **** ( p < .0001).
    Figure Legend Snippet: Biofilms were established by incubating A. fumigatus AF293 (1 × 10⁴ CFU/mL) in RPMI-1640 medium for 24 hours in the presence of cobicistat or elvitegravir (16 µg/mL), either alone or combined with a sub-inhibitory concentration of amphotericin B (0.015 µg/mL; 0.0075 × MIC). Biofilm biomass was quantified using crystal violet staining, followed by solubilization and absorbance measurement at 600 nm. Statistical analysis was performed using one-way ANOVA with Dunnett’s post hoc test. Significant reductions were observed for both AmB/COB and AmB/ELV combinations. Asterisks indicate significant differences relative to the untreated control **** ( p < .0001).

    Techniques Used: Concentration Assay, Staining, Control

    Mature biofilms of A. fumigatus AF293 were allowed to form over 24 hours prior to treatment with increasing concentrations of AmB/COB and AmB/ELV combinations. Following 24 hours of drug exposure, residual metabolic activity was quantified using the XTT reduction assay. Statistical analysis was performed using one-way ANOVA with Dunnett’s test. Significant reductions in metabolic activity were observed for AmB/COB and AmB/ELV. Asterisks indicate significant differences relative to the untreated control. * ( p = 0.0458) and **** ( p < 0.0001).
    Figure Legend Snippet: Mature biofilms of A. fumigatus AF293 were allowed to form over 24 hours prior to treatment with increasing concentrations of AmB/COB and AmB/ELV combinations. Following 24 hours of drug exposure, residual metabolic activity was quantified using the XTT reduction assay. Statistical analysis was performed using one-way ANOVA with Dunnett’s test. Significant reductions in metabolic activity were observed for AmB/COB and AmB/ELV. Asterisks indicate significant differences relative to the untreated control. * ( p = 0.0458) and **** ( p < 0.0001).

    Techniques Used: Activity Assay, Control

    Related Articles

    Concentration Assay:

    Article Title: Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species
    Article Snippet: The MedChemExpress (MCE) Antiviral Compound Library, consisting of 618 agents, was screened in vitro to identify compounds that enhance the antifungal activity of sub-inhibitory amphotericin B (AmB) against A. fumigatus . .. Each compound was tested in RPMI medium containing AmB at 0.25 μg/mL, which corresponds to 0.125 × the minimum inhibitory concentration (MIC), using the reference strain A. fumigatus AF293 (ATCC MYA-4609). ..



    Similar Products

    reference strain a fumigatus af293  (ATCC)
    95
    ATCC reference strain a fumigatus af293
    Screening of the MedChemExpress (MCE) Antiviral Compound Library at a final concentration of 16 µM against A. fumigatus <t>AF293</t> in the presence of a subinhibitory concentration of AmB (0.25 µg/mL). Fungal growth was assessed after 48 hours by measuring the optical density at 530 nm. Green dots indicate compounds that achieved ≥80% growth inhibition compared to the no-drug control. The chemical structures of the selected hit compounds, cobicistat (COB) and elvitegravir (ELV), are shown above the screening plot.
    Reference Strain A Fumigatus Af293, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/reference+strain+a+fumigatus+af293/Aspergillus+fumigatus+Fresenius/pmc13016342-102-24-29
    Average 95 stars, based on 1 article reviews
    reference strain a fumigatus af293 - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Screening of the MedChemExpress (MCE) Antiviral Compound Library at a final concentration of 16 µM against A. fumigatus AF293 in the presence of a subinhibitory concentration of AmB (0.25 µg/mL). Fungal growth was assessed after 48 hours by measuring the optical density at 530 nm. Green dots indicate compounds that achieved ≥80% growth inhibition compared to the no-drug control. The chemical structures of the selected hit compounds, cobicistat (COB) and elvitegravir (ELV), are shown above the screening plot.

    Journal: PLOS One

    Article Title: Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species

    doi: 10.1371/journal.pone.0344286

    Figure Lengend Snippet: Screening of the MedChemExpress (MCE) Antiviral Compound Library at a final concentration of 16 µM against A. fumigatus AF293 in the presence of a subinhibitory concentration of AmB (0.25 µg/mL). Fungal growth was assessed after 48 hours by measuring the optical density at 530 nm. Green dots indicate compounds that achieved ≥80% growth inhibition compared to the no-drug control. The chemical structures of the selected hit compounds, cobicistat (COB) and elvitegravir (ELV), are shown above the screening plot.

    Article Snippet: Each compound was tested in RPMI medium containing AmB at 0.25 μg/mL, which corresponds to 0.125 × the minimum inhibitory concentration (MIC), using the reference strain A. fumigatus AF293 (ATCC MYA-4609).

    Techniques: Drug discovery, Concentration Assay, Inhibition, Control

    A. fumigatus AF293 conidia (5 × 10⁴ conidia/mL) were incubated in RPMI-MOPS medium and fungal growth was monitored over a 48-hour period by measuring optical density at 530 nm at regular time intervals. (A) Growth kinetics of untreated control versus monotherapies: AmB at 0.25, 0.5, and 2 µg/mL; COB and ELV at 4 µg/mL. Only AmB at 2 µg/mL resulted in substantial inhibition, while sub-inhibitory doses and antiretrovirals alone had minimal impact. (B) Comparison of COB combinations: AmB 0.25/COB 4, AmB 0.5/COB 2, and AmB 0.5/COB 4 µg/mL. All combinations showed enhanced inhibition versus monotherapies, with the 0.5/4 pairing sustaining growth suppression across 48 hours. (C) Comparison of ELV combinations: AmB 0.25/ELV 4, AmB 0.5/ELV 2, and AmB 0.5/ELV 4 µg/mL. As with COB, the highest dose pairing (0.5/4) achieved the most durable inhibition.

    Journal: PLOS One

    Article Title: Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species

    doi: 10.1371/journal.pone.0344286

    Figure Lengend Snippet: A. fumigatus AF293 conidia (5 × 10⁴ conidia/mL) were incubated in RPMI-MOPS medium and fungal growth was monitored over a 48-hour period by measuring optical density at 530 nm at regular time intervals. (A) Growth kinetics of untreated control versus monotherapies: AmB at 0.25, 0.5, and 2 µg/mL; COB and ELV at 4 µg/mL. Only AmB at 2 µg/mL resulted in substantial inhibition, while sub-inhibitory doses and antiretrovirals alone had minimal impact. (B) Comparison of COB combinations: AmB 0.25/COB 4, AmB 0.5/COB 2, and AmB 0.5/COB 4 µg/mL. All combinations showed enhanced inhibition versus monotherapies, with the 0.5/4 pairing sustaining growth suppression across 48 hours. (C) Comparison of ELV combinations: AmB 0.25/ELV 4, AmB 0.5/ELV 2, and AmB 0.5/ELV 4 µg/mL. As with COB, the highest dose pairing (0.5/4) achieved the most durable inhibition.

    Article Snippet: Each compound was tested in RPMI medium containing AmB at 0.25 μg/mL, which corresponds to 0.125 × the minimum inhibitory concentration (MIC), using the reference strain A. fumigatus AF293 (ATCC MYA-4609).

    Techniques: Incubation, Control, Inhibition, Comparison

    (A) Brightfield microscopy images of A. fumigatus AF293 grown for 16 h in RPMI-1640 medium under the following conditions: untreated control, amphotericin B (AmB, 0.03 µg/mL), cobicistat (COB, 16 µg/mL), elvitegravir (ELV, 16 µg/mL), AmB/COB, and AmB/ELV. Images were acquired at 20 × magnification on a Nikon Eclipse Ti2 microscope, with a 100 µm scale bar shown. (B) Quantification of hyphal lengths under each condition was done using ImageJ software. For each variable, 15 hyphae were measured, and data are presented as mean. Statistical significance was assessed using one-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. Asterisks indicate significant differences relative to the untreated control, *** (P < 0.005) and **** (P < 0.0001).

    Journal: PLOS One

    Article Title: Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species

    doi: 10.1371/journal.pone.0344286

    Figure Lengend Snippet: (A) Brightfield microscopy images of A. fumigatus AF293 grown for 16 h in RPMI-1640 medium under the following conditions: untreated control, amphotericin B (AmB, 0.03 µg/mL), cobicistat (COB, 16 µg/mL), elvitegravir (ELV, 16 µg/mL), AmB/COB, and AmB/ELV. Images were acquired at 20 × magnification on a Nikon Eclipse Ti2 microscope, with a 100 µm scale bar shown. (B) Quantification of hyphal lengths under each condition was done using ImageJ software. For each variable, 15 hyphae were measured, and data are presented as mean. Statistical significance was assessed using one-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. Asterisks indicate significant differences relative to the untreated control, *** (P < 0.005) and **** (P < 0.0001).

    Article Snippet: Each compound was tested in RPMI medium containing AmB at 0.25 μg/mL, which corresponds to 0.125 × the minimum inhibitory concentration (MIC), using the reference strain A. fumigatus AF293 (ATCC MYA-4609).

    Techniques: Microscopy, Control, Software

    Biofilms were established by incubating A. fumigatus AF293 (1 × 10⁴ CFU/mL) in RPMI-1640 medium for 24 hours in the presence of cobicistat or elvitegravir (16 µg/mL), either alone or combined with a sub-inhibitory concentration of amphotericin B (0.015 µg/mL; 0.0075 × MIC). Biofilm biomass was quantified using crystal violet staining, followed by solubilization and absorbance measurement at 600 nm. Statistical analysis was performed using one-way ANOVA with Dunnett’s post hoc test. Significant reductions were observed for both AmB/COB and AmB/ELV combinations. Asterisks indicate significant differences relative to the untreated control **** ( p < .0001).

    Journal: PLOS One

    Article Title: Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species

    doi: 10.1371/journal.pone.0344286

    Figure Lengend Snippet: Biofilms were established by incubating A. fumigatus AF293 (1 × 10⁴ CFU/mL) in RPMI-1640 medium for 24 hours in the presence of cobicistat or elvitegravir (16 µg/mL), either alone or combined with a sub-inhibitory concentration of amphotericin B (0.015 µg/mL; 0.0075 × MIC). Biofilm biomass was quantified using crystal violet staining, followed by solubilization and absorbance measurement at 600 nm. Statistical analysis was performed using one-way ANOVA with Dunnett’s post hoc test. Significant reductions were observed for both AmB/COB and AmB/ELV combinations. Asterisks indicate significant differences relative to the untreated control **** ( p < .0001).

    Article Snippet: Each compound was tested in RPMI medium containing AmB at 0.25 μg/mL, which corresponds to 0.125 × the minimum inhibitory concentration (MIC), using the reference strain A. fumigatus AF293 (ATCC MYA-4609).

    Techniques: Concentration Assay, Staining, Control

    Mature biofilms of A. fumigatus AF293 were allowed to form over 24 hours prior to treatment with increasing concentrations of AmB/COB and AmB/ELV combinations. Following 24 hours of drug exposure, residual metabolic activity was quantified using the XTT reduction assay. Statistical analysis was performed using one-way ANOVA with Dunnett’s test. Significant reductions in metabolic activity were observed for AmB/COB and AmB/ELV. Asterisks indicate significant differences relative to the untreated control. * ( p = 0.0458) and **** ( p < 0.0001).

    Journal: PLOS One

    Article Title: Synergistic antifungal activity of antiretrovirals with amphotericin B against Aspergillus species

    doi: 10.1371/journal.pone.0344286

    Figure Lengend Snippet: Mature biofilms of A. fumigatus AF293 were allowed to form over 24 hours prior to treatment with increasing concentrations of AmB/COB and AmB/ELV combinations. Following 24 hours of drug exposure, residual metabolic activity was quantified using the XTT reduction assay. Statistical analysis was performed using one-way ANOVA with Dunnett’s test. Significant reductions in metabolic activity were observed for AmB/COB and AmB/ELV. Asterisks indicate significant differences relative to the untreated control. * ( p = 0.0458) and **** ( p < 0.0001).

    Article Snippet: Each compound was tested in RPMI medium containing AmB at 0.25 μg/mL, which corresponds to 0.125 × the minimum inhibitory concentration (MIC), using the reference strain A. fumigatus AF293 (ATCC MYA-4609).

    Techniques: Activity Assay, Control